Trial intelligence / Profile preview

Postoperative dexmedetomidine sedation and hemodynamics during extubation

2013-000702-31Phase 4Completed

Sponsor
Tays Sydänkeskus
Start
Apr 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of dexmedetomidine in cardiac morbidity (2 arms), sponsored by Tays Sydänkeskus. Primary endpoint: Maximum systolic blood pressure during extubation. Started Apr 2013; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

cardiac morbidity

Beyond the preview

Go deeper on 2013-000702-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-000702-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call